Is Fel d1 Based Component Resolved Diagnosis Associated With Airway Inflammation in Cat Sensitized Children?

Area of Science:

• Allergy and Immunology
• Pediatric Pulmonology
• Molecular Diagnostics

Background:

• Cat allergy management hinges on clinical outcomes, necessitating a deeper understanding of sensitization markers.
• Molecular diagnostics like Component Resolved Diagnosis (CRD/FEL D1) offer detailed allergen-specific IgE profiles.

Purpose of the Study:

• To investigate the association between molecular cat allergen sensitization (Fel d1) and airway inflammation markers (IL-4, IL-5, IL-13) in sensitized children.
• To correlate Fel d1 sensitization with asthma severity and allergic rhinitis symptoms.

Main Methods:

• Enrolled 80 children (4-17 years) with diagnosed cat allergen sensitization.
• Performed skin prick tests, component resolved diagnosis (CRD/FEL D1), and measured IL-4, IL-5, IL-13 in exhaled breath condensate (EBC).
• Recorded clinical data including asthma severity and allergic rhinitis symptom scores.

Main Results:

• 74% of subjects showed antibody positivity for Fel d1.
• Fel d1 positivity correlated with increased outdoor cat exposure and significantly higher asthma respiratory symptom severity scores (p=0.01).
• No significant differences in EBC IL-4, IL-5, or IL-13 levels were observed between Fel d1 positive and negative groups.

Conclusions:

• Component Resolved Diagnosis (CRD/FEL D1) positivity may indicate more severe respiratory symptoms in asthmatic children.
• Airway inflammation markers in exhaled breath condensate (EBC) did not correlate with Fel d1 sensitization.
• Clinical interpretation of CRD/FEL D1 results is crucial, especially when considering cat exposure and symptom severity.